Press release
Asia Pacific Immunohistochemistry Market is Projected to Grow to US$ 1,218.85 Million Growing at 8.7% CAGR Forecast By 2025 to 2034
Polaris Market Research's latest report explores the growth outlook of the Asia Pacific Immunohistochemistry Market for the period 2025 to 2034. This in-depth analysis covers market size, share, and major drivers influencing growth, offering valuable insights into future trends. Also, the report features a detailed assessment of the competitive landscape and a regional analysis.The market for immunohistochemistry across Asia Pacific is poised to register sustained growth in the coming years. The market was valued at USD 531.20 million in 2024 and is projected to grow to USD 1,218.85 million by 2034. It is anticipated to exhibit a CAGR of 8.7% during 2025-2034.
Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/asia-pacific-immunohistochemistry-market/request-for-sample
Market Definition:
Immunohistochemistry (IHC) is a laboratory technique used to detect the presence and location of specific antigens (proteins) within cells and tissues. It involves preparing a tissue section and treating it with an antibody that binds to the antigen of interest. Then, a labeling method is used to visualize the antibody-antigen complex. IHC is widely used in cancer research to identify specific markers in cancer cells to help diagnose different types and subsets of cancer. It's also used to detect the presence of specific antigens associated with various diseases. Researchers leverage IHC to study the expression and localization of proteins in tissues and cells for various purposes.
Market Dynamics:
Rising Geriatric Population:
Older adults have a higher risk of developing chronic conditions such as cardiovascular diseases, neurodegenerative disorders, and cancer. This consumer demographic benefits from detailed tissue diagnostic and analysis. With IHC, pathologists can detect specific cellular biomarkers and understand disease mechanisms at a molecular level. This makes IHC an essential tool for diagnosing chronic conditions among the elderly.
Increasing Product Development and Launches:
Major market companies are continually introducing advanced antibodies, staining kits, and detection systems. These advancements, along with the development of automated platforms, are improving the accuracy, speed, and reproducibility of IHC procedures. As a result, rising product development and launches are fueling the Asia Pacific immunohistochemistry market development.
Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/asia-pacific-immunohistochemistry-market/request-for-discount-pricing
Market Key Players:
The market is characterized by intense competition, driven by strategic partnerships, innnovations, and expansion.
A few of the major market players include:
• Abcam plc.
• Agilent Technologies, Inc.
• Amos Scientific PTY. LTD.
• Bio SB
• Bio-Rad Laboratories, Inc
• Cell Signaling Technology, Inc.
• Danaher Corporation
• HiMedia Laboratories
• IMGENEX INDIA Pvt. Ltd.
• Immuno-Biological Laboratories Co, Ltd.
• Kyowa Kirin Co., Ltd.
• Merck KGaA
• PathnSitu Biotechnologies Pvt Ltd
• PerkinElmer, Inc.
• Roche Ltd.
• Sino Biological, Inc.
• Thermo Fisher Scientific Inc.
Asia Pacific Immunohistochemistry Market Report Highlights:
• In terms of product, the antibodies segment dominated the Asia Pacific immunohistochemistry market share in 2024 due to their critical role in diagnostic and research applications. Researchers and clinicians across relied heavily on antibodies for the detection and analysis of specific cellular proteins.
• The kits segment is expected to grow at a rapid pace in the coming years, owing to its growing adoption in diagnostic laboratories and research institutions.
• Based on end use, the hospitals and diagnostic laboratories segment accounted for a major market share in 2024 due to increasing demand for accurate and early disease diagnosis.
• In the market, China accounted for a major market share in 2024 due to a rapidly expanding healthcare system, substantial government investments in cancer research, and a growing aging population susceptible to chronic illnesses.
• The market in India is projected to grow at a rapid pace in the coming years, owing to the expanding population, coupled with a rising cancer burden and increasing awareness of early diagnosis.
Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/asia-pacific-immunohistochemistry-market
Segmental Analysis:
The market segmentation is primarily based on product, application, end use, and country.
Based on product, the antibodies segment dominated the market in 2024. The segment's dominance is primarily driven by the crucial role of antibodies in diagnostic and research applications. The growing prevalence of cancer, which has led to the need for precise biomarker identification, further contributes to the leading market position of the segment.
By end use, the hospitals and diagnostic laboratories segment led the market in 2024, driven by rising demand for accurate and early disease diagnosis. Government initiatives aimed at improving healthcare infrastructure and expanding access to diagnostic services also drive the segment's dominance in the market.
Asia Pacific Immunohistochemistry Market, Product Outlook (Revenue - USD Million, 2019-2032)
• Antibodies
o Primary Antibodies
o Secondary Antibodies
• Reagents
o Histological Stains
o Blocking Sera and Reagents
o Chromogenic Substrates
o Fixation Reagents
o Organic Solvents
o Proteolytic Enzymes
o Diluents
o Other Reagents
• Equipment
o Slide Staining Systems
o Tissue Microarrays
o Tissue Processing Systems
o Slide Scanners
o Others
• Kits
Asia Pacific Immunohistochemistry Market, Application Outlook (Revenue - USD Million, 2019-2032)
• Diagnostics
o Cancer
o Infectious Diseases
o Cardiovascular Diseases
o Autoimmune Diseases
o Diabetes Mellitus
o Nephrological Diseases
o Others
• Research
Asia Pacific Immunohistochemistry Market, End Use Outlook (Revenue - USD Million, 2019-2032)
• Hospitals and Diagnostic Laboratories
• Research Institutes
• Others
By Country Outlook (Revenue, USD Million, 2020-2034)
• China
• Japan
• India
• Australia
• Rest of APAC
More Trending Latest Reports by Polaris Market Research:
Gene Therapy Market:
https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market
eClinical Solutions Market:
https://www.polarismarketresearch.com/industry-analysis/eclinical-solutions-market
Ostomy/Stoma Care Market:
https://www.polarismarketresearch.com/industry-analysis/ostomy-care-market
Dermatology Drugs Market:
https://www.polarismarketresearch.com/industry-analysis/dermatology-drugs-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asia Pacific Immunohistochemistry Market is Projected to Grow to US$ 1,218.85 Million Growing at 8.7% CAGR Forecast By 2025 to 2034 here
News-ID: 4056417 • Views: …
More Releases from Polaris Market Research & Consulting

Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of …
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. It…

Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 …
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected to…

Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin …
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billion…

Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 …
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reach…
More Releases for Asia
Asia Private Equity Firm, Asia Private Equity Management, Asia Private Equity Se …
The private equity market in China has been rapidly growing in recent years. Private equity (PE) refers to the purchase of shares in a company that are not publicly traded on a stock exchange. PE firms typically target companies that are undervalued or in need of capital for growth, and aim to improve the company's operations and financial performance before selling it at a higher value.
https://boomingfaucet.com/
Asia Private Equity Consulting
E-mail:nolan@pandacuads.com
In China,…
South East Asia Business Jet Market And Top Key Players are Asia Corporate Jet, …
By 2022, the South East Asia Business Jet Markets estimated to reach US$ XX Mn, up from US$ XX Mn in 2016, growing at a CAGR of XX% during the forecast period. The Global Business Jet Market, currently at 21 million USD, contributes the highest share in the market and is poised to grow at the fastest rate in the future. The three broad categories of business jets are Small,…
LIXIL Asia Presents Asia Pacific Property Awards
Through its power brands GROHE and American Standard, LIXIL Asia signs a three-year deal to become the Headline Sponsor of the Asia Pacific Property Awards from 2019 until 2022.
23rd January 2019: The International Property Awards, first established in 1993, are open to residential and commercial property professionals from around the globe. They celebrate the highest levels of achievement by companies operating within the architecture, interior design, real estate and property…
PEOPLEWAVE WINS ASIA TECH PODCAST PITCHDECK ASIA 2019 AWARDS
15 January 2019, Singapore – Peoplewave, Asia’s leading data-driven HR technology company, won the Asia Tech Podcast (ATP) Pitchdeck Asia 2019 Awards, being awarded “Startup Most Likely to Succeed in 2019".
The 2019 Pitchdeck Asia Awards is an opportunity for the Asian Startup Ecosystem to shine a spotlight on some of its best startups. The awards were decided by a public vote. More than 7,200 votes were cast by registered LinkedIn…
Undersea Defence Technology Asia, UDT Asia 2011
Latest Military Diving Technologies featured in UDT Asia
Equipping Asia’s navies with the latest diving technology for asymmetric warfare and
operations
SINGAPORE, 17 October 2011 - Naval diving and underwater special operations is a field that is
seeing increased attention and investment amongst navies in Asia. Units such as the Indonesian Navy‟s KOPASKA, the Republic of Singapore Navy‟s Naval Diving Unit (NDU), the Royal Malaysian Navy‟s PASKAL are increasingly utilising specialised equipment for conducting…
Asia Diligence – Specialist Investigative Due Diligence for Asia & Beyond
Asia Diligence today announced the opening of its European Customer Services office in the United Kingdom. The office is to be managed by Steve Fowler and will focus on providing services to Asia Diligence’s European customers. Asia Diligence is also planning to open a US office in the near future, which will provide customer service to its US and North American clients.
Asked to comment on the move, Luke Palmer, the…